Rolex Pharmaceuticals Limited
About Rolex Pharmaceuticals Limited
Data last updated:
Rolex Pharmaceuticals Limited is a public limited company based in Vadodara, Gujarat, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 03 July 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ1986PLC008767. Its GSTIN is 24AAICR1562R1ZV (Gujarat).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.93 Cr. It is led by directors including Dilipbhai Hariprasad Joshi (Managing Director) and Ragini Dilipkumar Joshi.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 4th Floor Mruduna Sadan Pratap Road, Vadodara, Gujarat, India – 390001.
As per the financials filed for FY 2022, the company reported a revenue of ₹15.63 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹6,282 (net margin 0.4%) and EBITDA of ₹7,639 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 94% over five years.
As per MCA filings, the company has satisfied charges of ₹1.54 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Rolex Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232GJ1986PLC008767, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232GJ1986PLC008767 | Current |
| L24232GJ1986PLC008767 | Previous |
| U24232GJ1986PTC008767 | Previous |
Contact details
Rolex Pharmaceuticals Limited's registered office is in Vadodara, Gujarat. Its e-mail address is in the company report.
- Email
- Registered Address4th Floor Mruduna Sadan Pratap Road, Vadodara, Gujarat, India – 390001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Rolex Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rolex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rolex Pharmaceuticals Limited, buy the company report.
Financials of Rolex Pharmaceuticals Limited
FY 2022 filings availableRolex Pharmaceuticals Limited reported revenue of ₹15.63 Lakh (up 180% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 94% over five years, including 180% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7,639 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6,282 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rolex Pharmaceuticals Limited, buy the company report.
Board of directors of Rolex Pharmaceuticals Limited
Rolex Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ragini Dilipkumar Joshi | Director | 06 Jan 1992 | 34 Years 9 Months | Current |
| Dilipbhai Hariprasad Joshi | Managing Director | 03 Jul 1986 | 40 Years 4 Months | Current |
| Amit Dilipkumar Joshi | Director | 01 Jun 2010 | 16 Years 5 Months | Current |
Peer comparison
Rolex Pharmaceuticals Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kingson Pharmaceuticals Private Limited | ₹15.84 Lakh (FY 2025) | 50.0% | Bhopal, Madhya Pradesh, India | |||
| Means Pharmaceuticals Private Limited | ₹15.82 Lakh (FY 2025) | 56.0% | Delhi, India | |||
| Yskp Pharmaceuticals Private Limited | ₹15.65 Lakh (FY 2025) | -3.0% | Thane, Maharashtra, India | |||
| Rolex Pharmaceuticals Limitedthis company | ₹15.63 Lakh (FY 2022) | ₹6,282 | 0.4% | 180.0% | Vadodara, Gujarat, India | |
| Mipro Pharmaceuticals Private Limited | ₹15.62 Lakh (FY 2024) | 16.0% | Lajpat Nagar, Delhi, India | |||
| Narzi Pharmaceuticals Private Limited | ₹15.51 Lakh (FY 2022) | 1634.0% | Nalbari, Assam, India |
To see the full peer comparison of Rolex Pharmaceuticals Limited, buy the company report.
Shareholding
The shareholding of Rolex Pharmaceuticals Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Rolex Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jan 1994 | 90315204 | Industrial Development Bank of India | ₹1.3 Cr | Satisfied | |
| 08 Jul 1993 | 90315120 | Bank of Baroda | ₹10 Lakh | Satisfied | |
| 27 Mar 1989 | 90314310 | Gujarat State Financial Corporation | ₹14.49 Lakh | Satisfied |
To see the full charge records of Rolex Pharmaceuticals Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Rolex Pharmaceuticals Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by an individual | Disposed |
To see the full case history of Rolex Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rolex Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rolex Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICR1562R1ZV | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rolex Pharmaceuticals Limited, buy the company report.
Recent activity
Rolex Pharmaceuticals Limited has 7 board changes on record since 1986: 5 appointments and 2 cessations. The latest: Sujal Manishbhai Patel ceased to be Additional Director on 20 Nov 2019.
4 earlier events are in the company report.
Frequently asked questions
Rolex Pharmaceuticals is an active public limited company based in Vadodara, Gujarat, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 03 July 1986 (40+ years old) and is registered under CIN U24232GJ1986PLC008767.
Rolex Pharmaceuticals has 3 current directors:
- Dilipbhai Hariprasad Joshi - Managing Director
- Ragini Dilipkumar Joshi - Director
- Amit Dilipkumar Joshi - Director
The latest financial statements of Rolex Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Rolex Pharmaceuticals is 24AAICR1562R1ZV, registered in Gujarat.
The CIN (Corporate Identification Number) of Rolex Pharmaceuticals is U24232GJ1986PLC008767. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rolex Pharmaceuticals has 1 court case on record: 1 filed against it.
Rolex Pharmaceuticals was incorporated on 03 July 1986, making it 40+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Rolex Pharmaceuticals by revenue are Kingson Pharmaceuticals Private Limited, Means Pharmaceuticals Private Limited, Yskp Pharmaceuticals Private Limited, Mipro Pharmaceuticals Private Limited, Narzi Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sujal Manishbhai Patel ceased to be Additional Director on 20 Nov 2019. Sujal Manishbhai Patel was appointed as Additional Director on 23 Apr 2018. Nilam Sanatkumar Trivedi ceased to be Director on 25 Mar 2017. Rolex Pharmaceuticals has 7 board changes on record in total.
The registered office of Rolex Pharmaceuticals is at 4th Floor Mruduna Sadan Pratap Road, Vadodara, Gujarat, India – 390001.
Rolex Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
